May 18, 2017 12:06 pm UTC| Business
MIAMI, May 18, 2017 -- OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability to accurately predict aggressive...
May 18, 2017 12:06 pm UTC| Business
MIAMI, May 18, 2017 -- OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability to accurately predict aggressive...
May 18, 2017 12:06 pm UTC| Business
MIAMI, May 18, 2017 -- OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability to accurately predict aggressive...
May 18, 2017 12:06 pm UTC| Business
MIAMI, May 18, 2017 -- OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability to accurately predict aggressive...
May 18, 2017 12:06 pm UTC| Business
MIAMI, May 18, 2017 -- OPKO Health, Inc. (NASDAQ:OPK), announces that data from a prospective study conducted at Veteran Affairs (VA) hospitals confirming the 4Kscore test’s ability to accurately predict aggressive...
May 18, 2017 12:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 18, 2017 -- Portola PharmaceuticalsInc.® (Nasdaq:PTLA) today announced that preclinical and clinical data on cerdulatinib in relapsed/refractory b-cell malignancies will be presented at...
May 18, 2017 12:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 18, 2017 -- Portola PharmaceuticalsInc.® (Nasdaq:PTLA) today announced that preclinical and clinical data on cerdulatinib in relapsed/refractory b-cell malignancies will be presented at...
India's 2025 Trade Push: Major FTAs & Global Partnerships Secured